LHS Variable Price and quantity of drugs in the market RHS Variable Stringency of regulation Source of Exogenous Variation Introduction of bioequivalence certification policy in Chile - Atal, Cuesta, and Sæthre (2022), “Quality Regulation and Competition: Evidence from Pharmaceutical Markets
Plausibly Exogenous [924] - Quality Regulation (08/10/2022)
Plausibly Exogenous [924] - Quality…
Plausibly Exogenous [924] - Quality Regulation (08/10/2022)
LHS Variable Price and quantity of drugs in the market RHS Variable Stringency of regulation Source of Exogenous Variation Introduction of bioequivalence certification policy in Chile - Atal, Cuesta, and Sæthre (2022), “Quality Regulation and Competition: Evidence from Pharmaceutical Markets